Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas

Oncology Reports

Volumn 8, Issue 2, 2001, Pages 369-372

  Yutani, Shigeru ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer vaccine; Cytotoxic T lymphocyte; Hepatocellular carcinoma; Specific immunotherapy; Tumor rejection antigen

Indexed keywords

ANTIBODY; DNA BINDING PROTEIN; HLA A ANTIGEN; HLA A24 ANTIGEN; SART1 PROTEIN, HUMAN; SMALL NUCLEAR RIBONUCLEOPROTEIN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BLOOD; CELL CULTURE; CYTOLOGY; CYTOTOXICITY; HUMAN; IMMUNOLOGY; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MONONUCLEAR CELL; PATHOLOGY; WESTERN BLOTTING;

ANTIBODIES; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CYTOTOXICITY, IMMUNOLOGIC; DNA-BINDING PROTEINS; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER; LIVER NEOPLASMS; NEOPLASM PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; TUMOR CELLS, CULTURED;

EID: 0035292677     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.2.369     Document Type: Article

References (2)

1. Traversari C, van der Bruggen P, Lucscher IF, Lurquin C, Chomez P, van Pel A, de Plaen E, Amar-Costesec A and Boon T: A non-apeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453-1457, 1992.
2. Van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, de Smet C, Traversari C, Townsend A and Boon T: A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24: 3038-3043, 1994.